FdaApplication
ANDA 212955
Identifiers
- fda_app_no: ANDA212955
Properties
| Property | Value |
|---|---|
| applicant_name | KNOA PHARMA LLC |
| application_type | ANDA |
| approval_date | 2022-02-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | EQ 2MG BASE/2ML (EQ 1MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
1 product